{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:25:53Z","timestamp":1784067953825,"version":"3.55.0"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T00:00:00Z","timestamp":1622073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The incidence of breast cancer has been gradually increasing in Korea. Recently, the elevated level of serum gamma-glutamyltransferase (GGT) has emerged to be associated with the development and progression of some malignancies. This study aimed to determine the effect of serum GGT levels on the risk of developing breast cancer in Korean women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We used National Health Insurance Service Health Checkup data to examine the association between serum GGT levels and breast cancer development in Korean women. Women aged 40 years or older who participated in the Korean National Health Screening Examination between January 2009 and December 2009 and who did not develop any cancer within 1-year post examination were included in this analysis (n = 3,109,506). Cox proportional hazard regression analysis was conducted to calculate hazard ratios (HRs) with 95% confidence intervals (CIs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, an elevated serum GGT level was associated with the increased risk of developing breast cancer; compared to the Q1 group, the Q4 group showed a significantly increased breast cancer risk (HR: 1.120,95% CI: 1.08\u20131.162). Such a relationship was stronger in post-menopausal women than pre-menopausal women (HR: 1.173, 95% CI: 1.107\u20131.243; HR: 1.070, 95% CI:1.019\u20131.124). Women with a high GGT level (Q4) were also at an increased risk of developing carcinoma <jats:italic>in situ<\/jats:italic> (CIS) (HR: 1.114, 95% CI: 1.04\u20131.192). In post-menopausal women, the Q4 group also exhibited higher CIS risk (HR: 1.266, 95% CI: 1.132\u20131.416). However, no significant difference in the risk of developing CIS was observed between the Q1 and Q4 groups in pre-menopausal women. Further analysis revealed that obese, post-menopausal women with a high GGT level (Q4) were associated with an increased risk of developing breast cancer (HR: 1.214, 95% CI: 1.125\u20131.31) and CIS (HR: 1.348, 95% CI: 1.159\u20131.569).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our study results demonstrate that increased serum GGT level is a risk factor for developing breast cancer. The post-menopausal women group with obesity and elevated serum GGT level showed the highest incidence of breast cancer. Thus, serum GGT concentration could be a novel and potential risk factor for breast cancer. Further validation in different ethnic groups would be warranted.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.668624","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T04:17:46Z","timestamp":1622089066000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Enhanced Susceptibility to Breast Cancer in Korean Women With Elevated Serum Gamma-Glutamyltransferase Levels: A Nationwide Population-Based Cohort Study"],"prefix":"10.3389","volume":"11","author":[{"given":"Aeran","family":"Seol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Ik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngjin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In Sil","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhwan","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HyunA","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung-Do","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Sang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31392-7","article-title":"The Global Burden of Women\u2019s Cancers: A Grand Challenge in Global Health","volume":"389","author":"Ginsburg","year":"2017","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer Statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4143\/crt.2020.203","article-title":"Prediction of Cancer Incidence and Mortality in Korea, 2020","volume":"52","author":"Jung","year":"2020","journal-title":"Cancer Res Treat"},{"key":"B5","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13098-019-0468-0","article-title":"Cardiovascular Risk and Obesity","volume":"11","author":"Cercato","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-010-0139-7","article-title":"Obesity and Cancer Risk: Recent Review and Evidence","volume":"13","author":"Basen-Engquist","year":"2011","journal-title":"Curr Oncol Rep"},{"key":"B7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1001\/jama.296.2.193","article-title":"Adult Weight Change and Risk of Postmenopausal Breast Cancer","volume":"296","author":"Eliassen","year":"2006","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2015.205","article-title":"Body Mass Index and Breast Cancer: Analysis of a Nation-Wide Population-Based Prospective Cohort Study on 1 393 985 Taiwanese Women","volume":"40","author":"Chen","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10549-020-05952-4","article-title":"Obesity and Breast Cancer Risk for Pre- and Postmenopausal Women Among Over 6 Million Korean Women","volume":"185","author":"Park","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-010-0683-1","article-title":"Is Breast Cancer the Same Disease in Asian and Western Countries","volume":"34","author":"Leong","year":"2010","journal-title":"World J Surg"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-50680-5","article-title":"Worldwide Age At Onset of Female Breast Cancer: A 25-Year Population-Based Cancer Registry Study","volume":"9","author":"Bidoli","year":"2019","journal-title":"Sci Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"818570","DOI":"10.1155\/2015\/818570","article-title":"Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk","volume":"2015","author":"Koenig","year":"2015","journal-title":"Dis Markers"},{"key":"B13","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/20014091084227","article-title":"Gamma Glutamyl Transferase","volume":"38","author":"Whitfield","year":"2001","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.09.005","article-title":"The Dark Side of Gamma-Glutamyltransferase (GGT): Pathogenic Effects of an \u2018Antioxidant\u2019 Enzyme","volume":"160","author":"Corti","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.552547","article-title":"\u03b3-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An\u00a0Epidemiological Investigation in a Cohort of 163 944 Austrian Adults","volume":"112","author":"Ruttmann","year":"2005","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/HJH.0000000000001204","article-title":"Gamma-Glutamyltransferase, Fatty Liver Index and Hepatic Insulin Resistance are Associated With Incident Hypertension in Two Longitudinal Studies","volume":"35","author":"Bonnet","year":"2017","journal-title":"J\u00a0Hypertension"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.128","article-title":"Gamma-Glutamyl Transferase: Risk and Prognosis of Cancer","volume":"106","author":"Fentiman","year":"2012","journal-title":"Br J Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/1724600820921869","article-title":"Gamma Glutamyl Transpeptidase as a Prognostic Biomarker in Hepatocellular Cancer Patients Especially With >5\u00a0Cm Tumors, Treated by Liver Transplantation","volume":"35","author":"Ince","year":"2020","journal-title":"Int J Biol Markers"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23714","article-title":"Prospective Study of the Association of Gamma-Glutamyltransferase With Cancer Incidence in Women","volume":"123","author":"Strasak","year":"2008","journal-title":"Int J Cancer"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605719","article-title":"gamma-Glutamyl Transferase and Breast Cancer Risk","volume":"103","author":"Fentiman","year":"2010","journal-title":"Br J Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2017.155","article-title":"Defining Obesity as a Disease","volume":"71","author":"Muller","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.03.010","article-title":"Gamma-Glutamyltransferase and Risk of Cancer in a Cohort of 545,460 Persons - the Swedish AMORIS Study","volume":"47","author":"Van Hemelrijck","year":"2011","journal-title":"Eur J Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-420117-0.00003-7","article-title":"Gamma-Glutamyl Transpeptidase: Redox Regulation and Drug Resistance","volume":"122","author":"Hanigan","year":"2014","journal-title":"Adv Cancer Res"},{"key":"B24","article-title":"Gamma-Glutamyltransferase of Cancer Cells At the Crossroads of Tumor Progression, Drug Resistance and Drug Targeting","volume":"30","author":"Corti","year":"2010","journal-title":"Anticancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.323","article-title":"Association of Gamma-Glutamyltransferase With Severity of Disease At Diagnosis and Prognosis of Ovarian Cancer","volume":"109","author":"Grimm","year":"2013","journal-title":"Br J Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.16","article-title":"Prognostic Significance of Gamma-Glutamyltransferase in Patients With Endometrial Cancer: A Multi-Centre Trial","volume":"106","author":"Seebacher","year":"2012","journal-title":"Br J Cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2005.10.005","article-title":"Expression of Gamma-Glutamyltransferase in Cancer Cells and its Significance in Drug Resistance","volume":"71","author":"Pompella","year":"2006","journal-title":"Biochem Pharmacol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.668624\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T04:17:49Z","timestamp":1622089069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.668624\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,27]]},"references-count":27,"alternative-id":["10.3389\/fonc.2021.668624"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.668624","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,27]]},"article-number":"668624"}}